Cite Filings / ORIC / 0001193125-22-310167

Feed Companies Filings Check

Sign in

424B5

Prospectus

Oric Pharmaceuticals, Inc. Filed 2022-12-21 Acc 0001193125-22-310167

Documents 1

424B5 Prospectus , d423180d424b5.htm

Around this filing

2026-02-23 424B5 Prospectus
2022-12-21 8-K Other events
2022-12-21 424B5 Prospectus
2022-12-16 4 Chief Medical Officer sold 2,089 shares at $3.25 ($6,789)
2022-12-16 4 Chief Financial Officer sold 2,089 shares at $3.25 ($6,789)
2022-12-16 4 President and CEO sold 5,764 shares at $3.25 ($18,733)
2021-05-06 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d423180d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…